Surgery Partners Stock Hits Day Low at $12.25 Amid Price Pressure

Surgery Partners, Inc., a small-cap company in the hospital industry, has experienced significant volatility today, with the stock hitting an intraday low of USD 12.25. The stock has seen a notable decline of 12.34% on March 3, 2026, which is considerably worse than the S&P 500's performance of -0.43% for the same day. Over the past week, Surgery Partners has dropped 9.49%, and its performance over the last month shows a decrease of 2.11%. The company has faced substantial challenges, with a staggering 42.0% decline over the past year, contrasting sharply with the S&P 500's gain of 17.36%. Year-to-date, the stock is down 9.9%, while the S&P 500 has increased by 0.49%. Financial metrics indicate that Surgery Partners has reported negative results for the last three consecutive quarters, with a net profit of -USD 13.29 million, reflecting a decline of 74.91%. The company's debt-to-equity ratio stands at a high 212.07%, and interest expenses have reached USD 73.3 million. These factors contribute to the stock's underperformance against the benchmark over the past three years, highlighting ongoing financial difficulties.